日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia.

对 IDH 突变型急性髓系白血病中的克隆和细胞结构进行解卷积。

Sirenko Maria, Lee Soobeom, Sun Zhengxi, Chaligne Ronan, Loghavi Sanam, Asimomitis Georgios, Brierley Charlotte K, Bernard Elsa, Cai Sheng F, Myers Robert M, Nadorp Bettina, Sango Junya, Lallo Morgan, Levine Max F, Domenico Dylan, Arango Ossa Juan E, Medina-Martinez Juan S, Menghrajani Kamal, Lasry Audrey, Mims Alice S, Desai Helee, Laganson Andrea, Famulare Chris, Patel Minal, Lozanski Gerard, Bolton Kelly L, Viny Aaron D, Roshal Mikhail, Levine Ross L, Papapetrou Eirini P, Stein Eytan M, Landau Dan A, Eisfeld Ann-Kathrin, Aifantis Iannis, Papaemmanuil Elli

TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environment

TP53突变和TET2缺陷协同作用,驱动白血病发生并建立免疫抑制环境。

Zhang, Pu; Whipp, Ethan C; Skuli, Sarah J; Gharghabi, Mehdi; Saygin, Caner; Sher, Steven A; Carroll, Martin; Pan, Xiangyu; Eisenmann, Eric D; Lai, Tzung-Huei; Harrington, Bonnie K; Chan, Wing Keung; Youssef, Youssef; Chen, Bingyi; Penson, Alex; Lewis, Alexander M; Castro, Cynthia R; Fox, Nina; Cihan, Ali; Le Luduec, Jean-Benoit; DeWolf, Susan; Kauffman, Tierney; Mims, Alice S; Canfield, Daniel; Phillips, Hannah; Williams, Katie E; Shaffer, Jami; Lozanski, Arletta; Doong, Tzyy-Jye; Lozanski, Gerard; Mao, Charlene; Walker, Christopher J; Blachly, James S; Daniyan, Anthony F; Alinari, Lapo; Baiocchi, Robert A; Yang, Yiping; Grieselhuber, Nicole R; Campbell, Moray J; Baker, Sharyn D; Blaser, Bradley W; Abdel-Wahab, Omar; Lapalombella, Rosa

LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclaxresistant chronic lymphocytic leukemia

LP-118 是一种新型 B 细胞淋巴瘤 2/超大抑制剂,在维奈克拉耐药性慢性淋巴细胞白血病模型中表现出疗效

Janani Ravikrishnan, Daisy Y Diaz-Rohena, Elizabeth Muhowski, Xiaokui Mo, Tzung-Huei Lai, Shrilekha Misra, Charmelle D Williams, John Sanchez, Andrew Mitchell, Suresh Satpati, Elizabeth Perry, Tierney Kaufman, Chaomei Liu, Arletta Lozanski, Gerard Lozanski, KerryA Rogers, Adam S Kittai, Seema A Bhat

Results of Cancer and Leukemia Group B 10102 (Alliance), a Phase 1/2 Study

癌症和白血病B组10102(Alliance)1/2期研究结果

Luskin, Marlise R; Yin, Jun; Lozanski, Gerard; Curran, Emily; Malnassy, Gregory; Mrózek, Krzysztof; Bloomfield, Clara D; Cataland, Spero R; Fulton, Noreen; Kolitz, Jonathan; Laplant, Betsy; Kour, Oudom; Powell, Bayard L; Vij, Ravi; Wang, Eunice S; Grinblatt, David; Stone, Richard M; Uy, Geoffrey L; Larson, Richard A; Stock, Wendy

Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

作者更正:新辅助阿特珠单抗治疗可切除非小细胞肺癌:一项开放标签、单臂 II 期试验

Chaft, Jamie E; Oezkan, Filiz; Kris, Mark G; Bunn, Paul A; Wistuba, Ignacio I; Kwiatkowski, David J; Owen, Dwight H; Tang, Yan; Johnson, Bruce E; Lee, Jay M; Lozanski, Gerard; Pietrzak, Maciej; Seweryn, Michal; Byun, Woo Yul; Schulze, Katja; Nicholas, Alan; Johnson, Ann; Grindheim, Jessica; Hilz, Stephanie; Shames, David S; Rivard, Chris; Toloza, Eric; Haura, Eric B; McNamee, Ciaran J; Patterson, G Alexander; Waqar, Saiama N; Rusch, Valerie W; Carbone, David P

Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL

A041202 研究的后续结果显示,伊布替尼治疗方案对老年慢性淋巴细胞白血病 (CLL) 患者持续有效。

Woyach, Jennifer A; Perez Burbano, Gabriela; Ruppert, Amy S; Miller, Cecelia; Heerema, Nyla A; Zhao, Weiqiang; Wall, Anna; Ding, Wei; Bartlett, Nancy L; Brander, Danielle M; Barr, Paul M; Rogers, Kerry A; Parikh, Sameer A; Stephens, Deborah M; Brown, Jennifer R; Lozanski, Gerard; Blachly, James; Nattam, Sreenivasa; Larson, Richard A; Erba, Harry; Litzow, Mark; Luger, Selina; Owen, Carolyn; Kuzma, Charles; Abramson, Jeremy S; Little, Richard F; Dinner, Shira; Stone, Richard M; Uy, Geoffrey; Stock, Wendy; Mandrekar, Sumithra J; Byrd, John C

Hairy cell leukemia variant and WHO classification correspondence Re: 5(th) edition WHO classification haematolymphoid tumors: lymphoid neoplasms

毛细胞白血病变异型与WHO分类的对应关系:第五版WHO血液淋巴瘤分类:淋巴瘤

Grever, Michael; Andritsos, Leslie; Anghelina, Mirela; Arons, Evgeny; Banerji, Versha; Barrientos, Jacqueline; Bhat, Seema A; Blachly, James; Broccoli, Alessandro; Call, Timothy; Dearden, Claire; Dietrich, Sascha; Else, Monica; Epperla, Narendranath; Fagarasanu, Andrei; Falini, Brunangelo; Forconi, Francesco; Gozzetti, Alessandro; Hampel, Paul; Hermel, David J; Iyengar, Sunil; Johnston, James B; Juliusson, Gunnar; Kreitman, Robert J; Lauria, Francesco; Lozanski, Gerard; Oakes, Christopher C; Parikh, Sameer A; Park, Jae; Quest, Graeme; Rai, Kanti; Ravandi, Farhad; Robak, Tadeusz; Rogers, Kerry A; Saven, Alan; Seymour, John F; Tadmor, Tamar; Tallman, Martin S; Tam, Constantine S; Tiacci, Enrico; Troussard, Xavier; Wörmann, Bernhard; Zent, Clive S; Zenz, Thorsten; Zinzani, Pier Luigi

Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2

SARS-CoV-2 Omicron 亚型 BQ.1、BQ.1.1、BA.4.6、BF.7 和 BA.2.75.2 的中和抵抗力增强

Panke Qu ,John P Evans ,Julia N Faraone ,Yi-Min Zheng ,Claire Carlin ,Mirela Anghelina ,Patrick Stevens ,Soledad Fernandez ,Daniel Jones ,Gerard Lozanski ,Ashish Panchal ,Linda J Saif ,Eugene M Oltz ,Kai Xu ,Richard J Gumina ,Shan-Lu Liu

Neutralization escape of Omicron XBB, BR.2, and BA.2.3.20 subvariants

Omicron XBB、BR.2 和 BA.2.3.20 亚型的中和逃逸

Julia N Faraone ,Panke Qu ,John P Evans ,Yi-Min Zheng ,Claire Carlin ,Mirela Anghelina ,Patrick Stevens ,Soledad Fernandez ,Daniel Jones ,Gerard Lozanski ,Ashish Panchal ,Linda J Saif ,Eugene M Oltz ,Richard J Gumina ,Shan-Lu Liu

Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal

来那度胺相关B细胞急性淋巴细胞白血病:临床和病理相关性以及对来那度胺停药的敏感性

Geyer, Mark B; Shaffer, Brian C; Bhatnagar, Bhavana; Mims, Alice S; Klein, Victoria; Dilip, Deepika; Glass, Jacob L; Lozanski, Gerard; Hassoun, Hani; Landau, Heather; Zhang, Yanming; Xiao, Wenbin; Roshal, Mikhail; Park, Jae H